ALLO
Price
$2.05
Change
-$0.13 (-5.96%)
Updated
Mar 10 closing price
Capitalization
457.09M
2 days until earnings call
AUTL
Price
$1.94
Change
-$0.07 (-3.48%)
Updated
Mar 10 closing price
Capitalization
534.9M
9 days until earnings call
Ad is loading...

ALLO vs AUTL

Header iconALLO vs AUTL Comparison
Open Charts ALLO vs AUTLBanner chart's image
Allogene Therapeutics
Price$2.05
Change-$0.13 (-5.96%)
Volume$3.93M
Capitalization457.09M
Autolus Therapeutics
Price$1.94
Change-$0.07 (-3.48%)
Volume$1.23M
Capitalization534.9M
ALLO vs AUTL Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. AUTL commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongBuy and AUTL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ALLO: $2.05 vs. AUTL: $1.93)
Brand notoriety: ALLO and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 62% vs. AUTL: 101%
Market capitalization -- ALLO: $457.09M vs. AUTL: $534.9M
ALLO [@Biotechnology] is valued at $457.09M. AUTL’s [@Biotechnology] market capitalization is $534.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileAUTL’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • AUTL’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while AUTL’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 5 bearish.
  • AUTL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AUTL is a better buy in the short-term than ALLO.

Price Growth

ALLO (@Biotechnology) experienced а +13.61% price change this week, while AUTL (@Biotechnology) price change was +10.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -8.82%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

ALLO is expected to report earnings on Apr 30, 2025.

AUTL is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($535M) has a higher market cap than ALLO($457M). ALLO YTD gains are higher at: -3.991 vs. AUTL (-17.660). AUTL has higher annual earnings (EBITDA): -192.51M vs. ALLO (-256.67M). AUTL has more cash in the bank: 657M vs. ALLO (292M). AUTL has less debt than ALLO: AUTL (52.2M) vs ALLO (85.1M). AUTL has higher revenues than ALLO: AUTL (10.1M) vs ALLO (43K).
ALLOAUTLALLO / AUTL
Capitalization457M535M85%
EBITDA-256.67M-192.51M133%
Gain YTD-3.991-17.66023%
P/E RatioN/AN/A-
Revenue43K10.1M0%
Total Cash292M657M44%
Total Debt85.1M52.2M163%
FUNDAMENTALS RATINGS
ALLO vs AUTL: Fundamental Ratings
ALLO
AUTL
OUTLOOK RATING
1..100
217
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
9091
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for ALLO (97). This means that AUTL’s stock grew somewhat faster than ALLO’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALLO (100). This means that AUTL’s stock grew similarly to ALLO’s over the last 12 months.

ALLO's SMR Rating (94) in the Biotechnology industry is in the same range as AUTL (96). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

ALLO's Price Growth Rating (90) in the Biotechnology industry is in the same range as AUTL (91). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

ALLO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AUTL (100). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOAUTL
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPLX22.97N/A
N/A
Morgan Stanley Inst Advantage L
EQNCX21.46N/A
N/A
MFS Equity Income C
TSOEX14.17N/A
N/A
Nuveen International Res Eq Retire
NSFHX12.35N/A
N/A
Natixis Target Retirement 2040 N
FIWCX10.89N/A
N/A
Fidelity SAI International Value Index

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-6.19%
CRSP - ALLO
59%
Loosely correlated
-4.81%
FATE - ALLO
58%
Loosely correlated
-8.24%
NTLA - ALLO
56%
Loosely correlated
-8.60%
PRME - ALLO
52%
Loosely correlated
-13.33%
BEAM - ALLO
49%
Loosely correlated
-9.80%
More

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with MGTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-3.73%
MGTX - AUTL
38%
Loosely correlated
-4.55%
CRSP - AUTL
37%
Loosely correlated
-4.81%
RCKT - AUTL
37%
Loosely correlated
-2.05%
KALV - AUTL
37%
Loosely correlated
+0.67%
VCYT - AUTL
36%
Loosely correlated
-5.09%
More